Journal of Pharma and Drug Innovation

Frequency : Quarterly
Editorial & Review Timeline
3 - 9 Days Initial Quality Review
14 Days Peer Evaluation Summary
80% Final Acceptance Rate After Peer Review
35 - 45 Days Complete Editorial Processing Time

Prof Hani A Alhadrami

Ph.D

  • Affiliation: Professor Consultant of Molecular Diagnostics and Medical Biotechnology
  • Department: Medical Biotechnology
  • University: King Abdulaziz University (KAU)
  • Email: hanialhadrami@kau.edu.sa
  • Country: Saudi Arabia

Prof. Hani A. Alhadrami is a Professor and Consultant of Molecular Diagnostics and Medical Biotechnology at the Faculty of Applied Medical Sciences, King Abdulaziz University, Jeddah, Saudi Arabia. He also serves as Head of the Nanobiotechnology for Medical Applications Research Group at the King Fahd Medical Research Center and Consultant Scientist at the Special Infectious Agents Unit (BSL-3) at KAU Hospital. He obtained his PhD in Medical Biotechnology from the University of Aberdeen (UK), an MSc in Microbiology and Biotechnology with Commendation, and a Diploma in Medical Education from KAU. Prof. Alhadrami is an inventor of multiple U.S. patents and has published over 100 peer-reviewed articles. His work focuses on molecular diagnostics, biosensing technologies, nanomedicine, and infectious disease diagnostics.

  • Founder & President, Saudi Society of Molecular Biology and Biotechnology (SSMBB)

  • Head, Nanobiotechnology for Medical Applications Research Group

  • Consultant Scientist, BSL-3 Special Infectious Agents Unit

  • Former Dean, Alghad International College for Applied Medical Sciences

  • Speaker at international scientific conferences (USA, UK, Europe, Middle East)

  • Alhadrami, H. A. et al.
    Fluorescent probe–based biosensors for rapid molecular diagnostics and infectious disease detection.
    Biosensors & Bioelectronics
    (High-impact journal in pharmaceutical diagnostics and biosensing)

  • Alhadrami, H. A. et al.
    Nanobiotechnology-driven molecular diagnostics: advances in biosensing platforms for clinical applications.
    Trends in Biotechnology

  • Alhadrami, H. A. et al.
    Development of novel natural compound formulations with antiviral activity against SARS-CoV-2.
    Journal of Medical Virology

  • Alhadrami, H. A. et al.
    Molecular diagnostics and biosensor technologies for emerging infectious diseases.
    Analytical Chemistry

  • Alhadrami, H. A. et al.
    Nanomedicine approaches for antiviral and antibacterial drug discovery.
    International Journal of Nanomedicine

  • Alhadrami, H. A. et al.
    Biotechnological innovations in molecular diagnostics and pharmaceutical development.
    Biotechnology Advances

  • Alhadrami, H. A. et al.
    Nanotechnology-enabled diagnostic and therapeutic platforms for global health applications.
    Frontiers in Pharmacology